PL2474306T3 - Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza - Google Patents

Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza

Info

Publication number
PL2474306T3
PL2474306T3 PL10812082T PL10812082T PL2474306T3 PL 2474306 T3 PL2474306 T3 PL 2474306T3 PL 10812082 T PL10812082 T PL 10812082T PL 10812082 T PL10812082 T PL 10812082T PL 2474306 T3 PL2474306 T3 PL 2474306T3
Authority
PL
Poland
Prior art keywords
composition
same
particle
medicinal
medicinal composition
Prior art date
Application number
PL10812082T
Other languages
English (en)
Inventor
Yasuki Kato
Atsushi Ishii
Original Assignee
Nanocarrier Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanocarrier Co., Ltd. filed Critical Nanocarrier Co., Ltd.
Publication of PL2474306T3 publication Critical patent/PL2474306T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL10812082T 2009-08-31 2010-08-31 Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza PL2474306T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009200681 2009-08-31
EP10812082.5A EP2474306B1 (en) 2009-08-31 2010-08-31 Particle composition and medicinal composition comprising same

Publications (1)

Publication Number Publication Date
PL2474306T3 true PL2474306T3 (pl) 2017-06-30

Family

ID=43628124

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10812082T PL2474306T3 (pl) 2009-08-31 2010-08-31 Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza

Country Status (13)

Country Link
US (1) US9415059B2 (pl)
EP (2) EP2474306B1 (pl)
JP (1) JP4912510B2 (pl)
KR (1) KR101689787B1 (pl)
CN (2) CN104758254B (pl)
AU (1) AU2010287391B2 (pl)
CA (1) CA2768651C (pl)
DK (1) DK2474306T3 (pl)
ES (1) ES2614615T3 (pl)
HU (1) HUE031793T2 (pl)
PL (1) PL2474306T3 (pl)
PT (1) PT2474306T (pl)
WO (1) WO2011025036A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI568453B (zh) * 2011-11-22 2017-02-01 原創生醫股份有限公司 具有螯合型複合微胞之藥物載體及其應用
SG11201706935PA (en) * 2015-02-27 2017-09-28 Nanocarrier Co Ltd Polymer treatment agent
WO2016137006A1 (ja) * 2015-02-27 2016-09-01 ナノキャリア株式会社 ポリマーミセル担体組成物およびポリマーミセル組成物
WO2017047364A1 (ja) * 2015-09-16 2017-03-23 株式会社島津製作所 ナノ粒子およびその製造方法
JP2019060866A (ja) * 2017-09-22 2019-04-18 旭化成ファーマ株式会社 液状医薬組成物の体内動態を予測する方法
CN109134778B (zh) * 2018-08-16 2021-03-09 西南民族大学 电荷翻转型聚合物胶束、载药胶束及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940003548U (ko) * 1992-08-14 1994-02-21 김형술 세탁물 건조기
TW520297B (en) 1996-10-11 2003-02-11 Sequus Pharm Inc Fusogenic liposome composition and method
JP2002508765A (ja) 1997-06-23 2002-03-19 アルザ コーポレイション リポソーム被包ポリヌクレオチド組成物および方法
SE9702776D0 (sv) 1997-07-22 1997-07-22 Pharmacia & Upjohn Ab Method of preparing pharmaceutical compositions
US6919372B1 (en) 1997-12-26 2005-07-19 Yamanouchi Pharmaceutical Co., Ltd. Sustained release pharmaceutical compositions
US6383811B2 (en) 1997-12-30 2002-05-07 Mirus Corporation Polyampholytes for delivering polyions to a cell
DE19954843C2 (de) 1999-11-09 2003-11-20 Novosom Ag Verfahren zur Verkapselung von Proteinen oder Peptiden in Liposomen, mit dem Verfahren hergestellte Liposomen und deren Verwendung
JP4659937B2 (ja) * 1999-11-19 2011-03-30 ナノキャリア株式会社 コア−シェル構造のポリイオンコンプレックスミセル
GB0009773D0 (en) * 2000-04-19 2000-06-07 Univ Cardiff Particulate composition
ATE345780T1 (de) * 2001-07-13 2006-12-15 Nanocarrier Co Ltd Lyophilisierende zusammensetzung von wirkstoff- verkapselnder polymer-mizelle und verfahren zu ihrer herstellung
WO2003059382A2 (en) 2001-12-28 2003-07-24 Supratek Pharma Inc. Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression
CN1761485B (zh) * 2003-03-20 2010-04-28 日本化药株式会社 含略微水溶性抗癌剂和新型嵌段共聚物的胶束制剂
CA2532228C (en) * 2003-07-16 2017-02-14 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
EP1664316B1 (en) * 2003-09-15 2012-08-29 Protiva Biotherapeutics Inc. Polyethyleneglycol-modified lipid compounds and uses thereof
CA2559029A1 (en) 2004-03-10 2005-10-06 Kyowa Hakko Kogyo Co., Ltd. Complex particles and coated complex particles
EP1773857A4 (en) * 2004-07-02 2009-05-13 Protiva Biotherapeutics Inc THE IMMUNE SYSTEM STIMULATING SIRNA MOLECULES AND APPLICATIONS THEREOF
US20060051405A1 (en) 2004-07-19 2006-03-09 Protiva Biotherapeutics, Inc. Compositions for the delivery of therapeutic agents and uses thereof
JP2006056864A (ja) * 2004-08-17 2006-03-02 Yukio Nagasaki 静電結合型ポリマー修飾リポソーム薬物キャリアの供給とその使用
US7829657B2 (en) 2005-02-10 2010-11-09 The University Of Tokyo Polycationically charged polymer and the use of the same as a carrier for nucleic acid
KR20080064827A (ko) * 2005-10-05 2008-07-09 도쿄 씨알오 가부시키가이샤 생체 적합성 블록 공중합체, 그 용도 및 제조법
WO2007136134A1 (ja) * 2006-05-23 2007-11-29 Nanocarrier Co., Ltd. 疎水性薬物内包ポリマーミセルの製造方法
KR101363498B1 (ko) 2006-07-18 2014-02-14 나노캬리아 가부시키가이샤 생리활성 폴리펩티드 또는 단백질 내포 고분자 폴리머 미셀및 그 제조방법
CA2927045A1 (en) 2006-10-03 2008-04-10 Muthiah Manoharan Lipid containing formulations
AU2007311980B2 (en) 2006-10-19 2012-05-31 Nano Mrna Co., Ltd. Block copolymer for drug complex and pharmaceutical composition
US8241647B2 (en) 2007-05-17 2012-08-14 Waseda University Amphiphilic molecule, molecular assembly comprising the amphiphilic molecule, and use of the molecular assembly
WO2010074540A2 (ko) * 2008-12-26 2010-07-01 주식회사 삼양사 음이온성 약물 함유 약제학적 조성물 및 그 제조방법

Also Published As

Publication number Publication date
US20120107377A1 (en) 2012-05-03
CN104758254B (zh) 2018-10-30
EP2474306A4 (en) 2013-11-27
US9415059B2 (en) 2016-08-16
AU2010287391B2 (en) 2016-02-25
DK2474306T3 (en) 2017-02-06
EP2474306B1 (en) 2016-11-09
CA2768651C (en) 2017-05-16
KR20120083280A (ko) 2012-07-25
EP3150194A1 (en) 2017-04-05
PT2474306T (pt) 2016-12-07
AU2010287391A1 (en) 2012-02-16
HUE031793T2 (en) 2017-07-28
CN104758254A (zh) 2015-07-08
ES2614615T3 (es) 2017-06-01
WO2011025036A1 (ja) 2011-03-03
CA2768651A1 (en) 2011-03-03
EP2474306A1 (en) 2012-07-11
JP4912510B2 (ja) 2012-04-11
CN102481255B (zh) 2015-04-22
CN102481255A (zh) 2012-05-30
JPWO2011025036A1 (ja) 2013-01-31
KR101689787B1 (ko) 2016-12-26

Similar Documents

Publication Publication Date Title
IL253870B (en) Certain amino-pyrimidines and pharmaceutical preparations containing them
IL217912A (en) History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
ZA201200722B (en) Pharmaceutical composition and administrations thereof
IL214911A0 (en) Solfonylated tetrahydroazolopyrazines and their use as medicinal products
SG10201403696UA (en) Therapeutic compounds and compositions
IL218212A0 (en) Therapeutic methods and compositions
PL2579839T3 (pl) Kompozycje perfumeryjne i ich zastosowania
PT2474522E (pt) Agomelatina e composições farmacêuticas que contêm a mesma
PL2605757T3 (pl) Preparaty oparte na nalbufinie i ich zastosowania
PT2251006T (pt) Micropartículas e suas composições farmacêuticas
ZA201201727B (en) Indenone derivative and pharmaceutical composition comprising same
ZA201200079B (en) Pharmaceutical compositions and solid forms
PL2474306T3 (pl) Kompozycja w postaci cząstek stałych i zawierająca ją kompozycja lecznicza
EP2445895A4 (en) DITHIOCTATE OF PIPERAZINE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
GB0908174D0 (en) Steroid containing composition and uses thereof
GB0902429D0 (en) Compositions and their use
EP2415463A4 (en) MEDICAL PARTICLE COMPOSITION
EP2461870A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
GB0902648D0 (en) Pharmaceutical compounds and compositions
PL2236145T3 (pl) Kompozycja farmaceutyczna i lek złożony
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
IL219018A (en) Radzolid Pharmaceuticals and Uses
IL217137A0 (en) Medicinal and herbal composition and uses thereof
GB0908317D0 (en) Pharmaceutical compounds and compositions